Natural killer cell alloreactivity is not beneficial in haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for multiple myeloma: Results of a prospective phase 2 clinical trial
Van Elssen, Catharina, Van Gorkom, Gwendolyn, Wieten, Lotte, Borne, Peter von dem, Meijer, Ellen, Bos, GerardVolume:
19
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.498
Date:
October, 2019
Fichier:
PDF, 84 KB
2019